Case—control study of stereotactic radiosurgery for recurrent glioblastoma multiforme

View More View Less
  • 1 Division of Radiation Oncology and the Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object. The role of stereotactic radiosurgery (SRS) for recurrent glioblastoma multiforme (GBM) was evaluated in a case—control study.

Methods. All patients who underwent SRS for recurrent GBM before March 2003 formed the case group. A control group of patients who did not undergo SRS was created from an institutional database, and each case was matched for known prognostic factors in GBM. The medical and neuroimaging records of all the patients were reviewed, and survival and treatment outcomes were recorded.

The case and control groups were well matched with regard to demographics and pre-SRS interventions. In the control group, the date on which magnetic resonance imaging identified a recurrent lesion that would have been eligible for SRS was deemed the “SRS” date. The number of surgeries performed in the control group was statistically higher than that in the case group. The median duration of overall survival from diagnosis was 26 months in the case group and 23 months in the control group. From the date of SRS or “SRS”, the median duration of survival was 11 months in the case group and 10 months in the control group, a difference that was not statistically significant.

Conclusions. It appears that a subgroup of patients with GBMs has a higher than expected median survival duration despite the initial prognostic factors. In patients with localized recurrences, survival may be prolonged by applying aggressive local disease management by using either SRS or resection to equal advantage.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Anita Mahajan, M.D., Division of Radiation Oncology, University of Texas, M. D. Anderson Cancer Center, Unit 097, 1515 Holcombe Boulevard, Houston, Texas 77030. email: amahajan@mdanderson.org.
  • 1.

    Chamberlain MC, & Tsao-Wei DD: Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. Cancer 100:12131220, 2004 Chamberlain MC, Tsao-Wei DD: Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. Cancer 100:1213–1220, 2004

    • Search Google Scholar
    • Export Citation
  • 2.

    Chao ST, , Suh JT, , Raja S, , Lee SY, & Barnett G: The sensitivity and specificity of FDG Pet in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96:191197, 2001 Chao ST, Suh JT, Raja S, Lee SY, Barnett G: The sensitivity and specificity of FDG Pet in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96:191–197, 2001

    • Search Google Scholar
    • Export Citation
  • 3.

    Chua SL, , Rosenthal MA, , Wong SS, , Ashley DM, , Woods AM, & Dowling A, et al: Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neurooncology 6:3843, 2004 Chua SL, Rosenthal MA, Wong SS, Ashley DM, Woods AM, Dowling A, et al: Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neurooncology 6:38–43, 2004

    • Search Google Scholar
    • Export Citation
  • 4.

    Curran WJ Jr, , Scott CB, , Horton J, , Nelson JS, , Weinstein AS, & Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704710, 1993 Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704–710, 1993

    • Search Google Scholar
    • Export Citation
  • 5.

    Frankel SA, & German WJ: Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg 15:489503, 1958 Frankel SA, German WJ: Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment. J Neurosurg 15:489–503, 1958

    • Search Google Scholar
    • Export Citation
  • 6.

    Hau P, , Baumgart U, , Pfeifer K, , Bock A, , Jauch T, & Dietrich J, et al: Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98:26782686, 2003 Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, et al: Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 98:2678–2686, 2003

    • Search Google Scholar
    • Export Citation
  • 7.

    Kaplan EL, & Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457481, 1958 Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958

    • Search Google Scholar
    • Export Citation
  • 8.

    Karnofsky DA, & Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, p 196 Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949, p 196

    • Search Google Scholar
    • Export Citation
  • 9.

    Keles GE, , Lamborn KR, , Chang SM, , Prados MD, & Berger MS: Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg 100:4146, 2004 Keles GE, Lamborn KR, Chang SM, Prados MD, Berger MS: Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. J Neurosurg 100:41–46, 2004

    • Search Google Scholar
    • Export Citation
  • 10.

    Kelly KA, , Kirkwood JM, & Kapp DS: Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat Rev 11:126, 1984 Kelly KA, Kirkwood JM, Kapp DS: Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat Rev 11:1–26, 1984

    • Search Google Scholar
    • Export Citation
  • 11.

    Kleihues P, & Cavenee W (eds): Pathology and Genetics Tumours of the Nervous System. Lyon, France: IARC Press, 2000 Kleihues P, Cavenee W (eds): Pathology and Genetics Tumours of the Nervous System. Lyon, France: IARC Press, 2000

    • Search Google Scholar
    • Export Citation
  • 12.

    Larson DA, , Suplica JM, , Chang SM, , Lamborn KR, , McDermott MW, & Sneed PK, et al: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neurooncology 6:119126, 2004 Larson DA, Suplica JM, Chang SM, Lamborn KR, McDermott MW, Sneed PK, et al: Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neurooncology 6:119–126, 2004

    • Search Google Scholar
    • Export Citation
  • 13.

    Loeffler JS, , Alexander E III, , Shea WM, , Wen PY, , Fine HA, & Kooy HM, et al: Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10:13791385, 1992 Loeffler JS, Alexander E III, Shea WM, Wen PY, Fine HA, Kooy HM, et al: Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10:1379–1385, 1992

    • Search Google Scholar
    • Export Citation
  • 14.

    Masciopinto JE, , Levin AB, , Mehta MP, & Rhode BS: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82:530535, 1995 Masciopinto JE, Levin AB, Mehta MP, Rhode BS: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82:530–535, 1995

    • Search Google Scholar
    • Export Citation
  • 15.

    Mehta MP, , Masciopinto J, , Rozental J, , Levin A, , Chappell R, & Bastin K, et al: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30:541549, 1994 Mehta MP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, et al: Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30:541–549, 1994

    • Search Google Scholar
    • Export Citation
  • 16.

    Rock JP, , Hearshen D, , Scarpace L, , Croteau D, , Gutierrez J, & Fisher JL, et al: Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912920, 2002 Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, et al: Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912–920, 2002

    • Search Google Scholar
    • Export Citation
  • 17.

    Ross DA, , Sandler HM, , Balter JM, , Hayman JA, , Archer PG, & Auer DL: Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175181, 2002 Ross DA, Sandler HM, Balter JM, Hayman JA, Archer PG, Auer DL: Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–181, 2002

    • Search Google Scholar
    • Export Citation
  • 18.

    Sarkaria JN, , Mehta MP, , Loeffler JS, , Buatti JM, , Chappell RJ, & Levin AB, et al: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32:931941, 1995 Sarkaria JN, Mehta MP, Loeffler JS, Buatti JM, Chappell RJ, Levin AB, et al: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32:931–941, 1995

    • Search Google Scholar
    • Export Citation
  • 19.

    Scott CB, , Scarantino C, , Urtasun R, , Movsas B, , Jones CU, & Simpson JR, et al: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90—06. Int J Radiat Oncol Biol Phys 40:5155, 1998 Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, et al: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90—06. Int J Radiat Oncol Biol Phys 40:51–55, 1998

    • Search Google Scholar
    • Export Citation
  • 20.

    Shaw E, , Scott C, , Souhami L, , Dinapoli R, , Kline R, & Loeffler J, et al: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90—05. Int J Radiat Oncol Biol Phys 47:291298, 2000 Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al: Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90—05. Int J Radiat Oncol Biol Phys 47:291–298, 2000

    • Search Google Scholar
    • Export Citation
  • 21.

    Shaw EG, , Seiferheld W, , Scott C, , Coughlin C, , Leibel S, & Curran W, et al: Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. Int J Radiat Oncol Biol Phys 57:S135S136, 2003 Shaw EG, Seiferheld W, Scott C, Coughlin C, Leibel S, Curran W, et al: Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. Int J Radiat Oncol Biol Phys 57:S135–S136, 2003

    • Search Google Scholar
    • Export Citation
  • 22.

    Shinoda J, , Yano H, , Ando H, , Ohe N, , Sakai N, & Saio M, et al: Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery. Brain Tumor Pathol 19:8392, 2002 Shinoda J, Yano H, Ando H, Ohe N, Sakai N, Saio M, et al: Radiological response and histological changes in malignant astrocytic tumors after stereotactic radiosurgery. Brain Tumor Pathol 19:83–92, 2002

    • Search Google Scholar
    • Export Citation
  • 23.

    Shrieve DC, , Alexander E III, , Black PM, , Wen PY, , Fine HA, & Kooy HM, et al: Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90:7277, 1999 Shrieve DC, Alexander E III, Black PM, Wen PY, Fine HA, Kooy HM, et al: Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg 90:72–77, 1999

    • Search Google Scholar
    • Export Citation
  • 24.

    Shrieve DC, , Alexander E III, , Wen PY, , Fine HA, , Kooy HM, & Black PM, et al: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275284, 1995 Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PM, et al: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275–284, 1995

    • Search Google Scholar
    • Export Citation
  • 25.

    Sneed PK, , Gutin PH, , Prados MD, , Phillips TL, , Weaver KA, & Wara WM, et al: Brachytherapy of brain tumors. Stereotact Funct Neurosurg 59:157165, 1992 Sneed PK, Gutin PH, Prados MD, Phillips TL, Weaver KA, Wara WM, et al: Brachytherapy of brain tumors. Stereotact Funct Neurosurg 59:157–165, 1992

    • Search Google Scholar
    • Export Citation
  • 26.

    Sneed PK, , Lamborn KR, , Larson DA, , Prados MD, , Malec MK, & McDermott MW, et al: Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 35:3744, 1996 Sneed PK, Lamborn KR, Larson DA, Prados MD, Malec MK, McDermott MW, et al: Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 35:37–44, 1996

    • Search Google Scholar
    • Export Citation
  • 27.

    Souhami L, , Seiferheld W, , Brachman D, , Podgorsak EB, , Werner-Wasik M, & Lustig R, et al: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93—05 protocol. Int J Radiat Oncol Biol Phys 60:853860, 2004 Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, et al: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93—05 protocol. Int J Radiat Oncol Biol Phys 60:853–860, 2004

    • Search Google Scholar
    • Export Citation
  • 28.

    Stupp R, , Dietrich PY, , Ostermann Kraljevic S, , Pica A, , Maillard I, & Maeder P, et al: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:13751382, 2002 Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, et al: Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375–1382, 2002

    • Search Google Scholar
    • Export Citation
  • 29.

    Stupp R, , Mason WP, , Van Den Bent MJ, , Weller M, , Fisher B, & Taphoorn M, et al: Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group. J Clin Oncol 22 (Suppl):2, 2004 (Abstract) Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn M, et al: Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group. J Clin Oncol 22 (Suppl):2, 2004 (Abstract)

    • Search Google Scholar
    • Export Citation
  • 30.

    Voynov G, , Kaufman S, , Hong T, , Pinkerton A, , Simon R, & Dowsett R: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 25:606611, 2002 Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 25:606–611, 2002

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 571 157 33
Full Text Views 197 23 0
PDF Downloads 133 22 0
EPUB Downloads 0 0 0